Position in AMGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,090,694
+$20,451 QoQ
Shares Held
8,535
-2.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#1,058
of 3,139 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Valmark Advisers, Inc. holds $25,445,603 across 11 Drug Manufacturers - General names. AMGN ranks #4 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,846 | $7,011,868 | |
| 2 | JNJ |
Johnson & Johnson
|
23,608 | $5,995,723 | |
| 3 | MRK |
Merck & Co., Inc.
|
26,899 | $3,456,521 | |
| 4 | AMGN |
Amgen Inc
This page
|
8,535 | $3,090,694 | |
| 5 | ABBV |
AbbVie Inc.
|
10,340 | $2,601,957 | |
| 6 | NVS |
Novartis AG
|
8,050 | $1,261,596 | |
| 7 | PFE |
Pfizer Inc
|
33,525 | $807,282 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,261 | $411,994 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,090,694 | 8,535 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $3,070,243 | 8,726 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $2,812,574 | 8,593 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $2,421,840 | 8,582 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $2,433,594 | 8,716 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $2,729,801 | 8,762 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $2,326,993 | 8,928 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $2,738,140 | 8,498 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $2,689,882 | 8,609 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,440,034 | 8,582 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $2,314,528 | 8,036 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $2,147,661 | 7,991 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,768,833 | 7,967 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,941,010 | 8,029 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $2,049,379 | 7,803 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,646,321 | 7,304 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $1,773,170 | 7,288 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,752,711 | 7,248 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,552,742 | 6,902 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,519,171 | 7,144 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,754,268 | 7,197 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,749,880 | 7,033 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,508,275 | 6,560 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $259,243 | 1,020 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $242,464 | 1,028 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $215,907 | 1,065 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||